Wikidata

(Q52603113)

English

The Molecular Targets of Swertiamarin and its Derivatives Confer Anti-Diabetic and Anti-Hyperlipidemic Effects.

scientific article published on 5 April 2018

In more languages

Statements

title
The Molecular Targets of Swertiamarin and its Derivatives Confer Anti-Diabetic and Anti-Hyperlipidemic Effects. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
29623834
retrieved
4 May 2018
reference URL
http://europepmc.org/abstract/MED/29623834

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q52603113&oldid=1276608816"